By James A. Lyons
By arming the rebels, we're aiding al Qaeda
Thoughtful analysis, straight reporting, maybe an appreciation? Sen. Jim DeMint had no press honeymoon upon announcing his bold career switch from U.S. senator to incoming president of the Heritage Foundation.
Medicare advisers on Wednesday supported the effectiveness of the prostate cancer drug Provenge, an innovative therapy that has prompted questions about the cost of medical care and the government's role in paying for it.
